Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allocetra-OTS in Adult Sepsis
NCT04612413Phase 2Completed
- Sponsor
- Enlivex Therapeutics
- Start
- Nov 2020
- Primary completion
- Jan 2024
- Modality
- Cell Therapies
- Countries
- 5
01
Overview
A Phase 2 trial of Allocetra in sepsis, sponsored by Enlivex Therapeutics. Started Nov 2020; status: completed.
02
Drugs
Allocetra
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT04612413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04612413.